000141122 001__ 141122
000141122 005__ 20240229105119.0
000141122 0247_ $$2doi$$a10.1097/CEJ.0000000000000243
000141122 0247_ $$2pmid$$apmid:29369941
000141122 0247_ $$2ISSN$$a0959-8278
000141122 0247_ $$2ISSN$$a1473-5709
000141122 037__ $$aDKFZ-2018-01656
000141122 041__ $$aeng
000141122 082__ $$a610
000141122 1001_ $$0P:(DE-He78)bf5409aed74a0923d9402c2c7ad620aa$$aWeberpals, Janick$$b0$$eFirst author$$udkfz
000141122 245__ $$aComment on: β Blocker use and mortality in cancer patients: systematic review and meta-analysis of observational studies (Zhong et al., 2015; published Epub ahead of print 3 September 2015).
000141122 260__ $$aPhiladelphia, Pa. [u.a.]$$bLippincott Williams & Wilkins$$c2018
000141122 3367_ $$2DRIVER$$aarticle
000141122 3367_ $$2DataCite$$aOutput Types/Journal article
000141122 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1540555445_23501
000141122 3367_ $$2BibTeX$$aARTICLE
000141122 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000141122 3367_ $$00$$2EndNote$$aJournal Article
000141122 536__ $$0G:(DE-HGF)POF3-313$$a313 - Cancer risk factors and prevention (POF3-313)$$cPOF3-313$$fPOF III$$x0
000141122 588__ $$aDataset connected to CrossRef, PubMed,
000141122 650_7 $$2NLM Chemicals$$aAdrenergic beta-Antagonists
000141122 7001_ $$0P:(DE-He78)7d7ee36ed0313bbc4c91bc3df5950107$$aCarr, Prudence$$b1$$udkfz
000141122 7001_ $$0P:(DE-He78)6c5d058b7552d071a7fa4c5e943fff0f$$aHoffmeister, Michael$$b2$$udkfz
000141122 7001_ $$0P:(DE-He78)bbfe0ebad1e3b608bca2b49d4f86bd09$$aJansen, Lina$$b3$$eLast author$$udkfz
000141122 773__ $$0PERI:(DE-600)2025799-5$$a10.1097/CEJ.0000000000000243$$gVol. 27, no. 1, p. 103 - 104$$n1$$p103 - 104$$tEuropean journal of cancer prevention$$v27$$x0959-8278$$y2018
000141122 909CO $$ooai:inrepo02.dkfz.de:141122$$pVDB
000141122 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)bf5409aed74a0923d9402c2c7ad620aa$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000141122 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)7d7ee36ed0313bbc4c91bc3df5950107$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000141122 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)6c5d058b7552d071a7fa4c5e943fff0f$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000141122 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)bbfe0ebad1e3b608bca2b49d4f86bd09$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000141122 9131_ $$0G:(DE-HGF)POF3-313$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vCancer risk factors and prevention$$x0
000141122 9141_ $$y2018
000141122 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz
000141122 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000141122 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000141122 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bEUR J CANCER PREV : 2017
000141122 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000141122 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000141122 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000141122 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000141122 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine
000141122 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000141122 9201_ $$0I:(DE-He78)C070-20160331$$kC070$$lKlinische Epidemiologie und Alternsforschung$$x0
000141122 980__ $$ajournal
000141122 980__ $$aVDB
000141122 980__ $$aI:(DE-He78)C070-20160331
000141122 980__ $$aUNRESTRICTED